STOCK TITAN

AbbVie to Present at the Bernstein 38th Annual Strategic Decisions Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AbbVie (NYSE: ABBV) will participate in the Bernstein 38th Annual Strategic Decisions Conference on June 1, 2022, at 10:00 a.m. Central Time. Richard A. Gonzalez, chairman and CEO, will present. A live audio webcast will be available on AbbVie's Investor Relations website, with an archived version accessible later the same day.

AbbVie focuses on discovering and delivering innovative medicines across various therapeutic areas, including immunology, oncology, and neurology. For more information, visit www.abbvie.com.

Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., May 25, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1, 2022. Richard A. Gonzalez, chairman and chief executive officer, will present at 10:00 a.m. Central Time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-bernstein-38th-annual-strategic-decisions-conference-301554489.html

SOURCE AbbVie

FAQ

When is AbbVie's presentation at the Bernstein Conference?

AbbVie's presentation at the Bernstein 38th Annual Strategic Decisions Conference is scheduled for June 1, 2022, at 10:00 a.m. Central Time.

How can I access AbbVie's conference presentation?

You can access AbbVie's conference presentation via a live audio webcast on their Investor Relations website.

Who is presenting for AbbVie at the conference?

Richard A. Gonzalez, chairman and CEO of AbbVie, will be presenting at the conference.

What is AbbVie's mission?

AbbVie's mission is to discover and deliver innovative medicines that address serious health issues today and meet future medical challenges.

What therapeutic areas does AbbVie focus on?

AbbVie focuses on several therapeutic areas, including immunology, oncology, neuroscience, eye care, virology, women's health, and gastroenterology.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

309.55B
1.77B
0.1%
73.43%
1.05%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NORTH CHICAGO